-
Something wrong with this record ?
Bioelectrical cochlear noise and its contralateral suppression: relation to background activity of the eighth nerve and effects of sedation and anesthesia
da Costa D Lima, JP Erre, de Sauvage R Charlet, J Popelar, JM Aran
Language English Country Germany
Document type Research Support, Non-U.S. Gov't
Grant support
IZ3108
MZ0
CEP Register
Digital library NLK
Full text - Část
Source
NLK
ProQuest Central
from 1997-08-01 to 1997-12-31
Nursing & Allied Health Database (ProQuest)
from 1997-08-01 to 1997-12-31
Health & Medicine (ProQuest)
from 1997-08-01 to 1997-12-31
Psychology Database (ProQuest)
from 1997-08-01 to 1997-12-31
PubMed
9348125
Knihovny.cz E-resources
- MeSH
- Acoustic Stimulation MeSH
- Aminoglycosides MeSH
- Anesthesia MeSH
- Anti-Bacterial Agents pharmacology MeSH
- Diuretics pharmacology MeSH
- Functional Laterality physiology drug effects MeSH
- Furosemide pharmacology MeSH
- Deafness physiopathology MeSH
- Hypnotics and Sedatives * pharmacology MeSH
- Cochlea physiology drug effects MeSH
- Ethacrynic Acid pharmacology MeSH
- Guinea Pigs MeSH
- Vestibulocochlear Nerve physiology drug effects MeSH
- Evoked Potentials, Auditory * drug effects MeSH
- Body Temperature physiology MeSH
- Animals MeSH
- Check Tag
- Guinea Pigs MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
The bioelectrical activity of the cochlea, without any ipsilateral acoustic stimulation, was recorded in awake guinea pigs (GPs) between electrodes chronically implanted at the round window (RW) and the skull. Measuring its power in the band centered around 1.0 kHz (0.5-2.5 kHz) provided an indirect measure of the ensemble background (EBA) activity of the eighth nerve. Contralateral white-noise (CLWN) stimulation reduced this EBA, presumably by activation of medial olivocochlear fibers. The aim of the investigation was to validate measurements of EBA and of its contralateral suppression in order to study the medial efferent function. The first goal was to find the best conditions for recording the EBA in the absence of ipsilateral stimulation and for studying its suppression by contralateral acoustic stimulation, which implies that no noise was generated by the experimental animal. Thus recordings were compared in normal, awake GPs and in GPs under sedation with xylazine, anesthetized with a combination of xylazine and ketamine, and with and without temperature regulation. In order to monitor the effects of sedation and anesthesia, the recordings were analyzed not only in the 0.5- to 2.5-kHz frequency band but also in the other frequency bands, 5-50 Hz, 50-150 Hz, and 150-500 Hz, which presumably include general central and neuromuscular contributions. The results show that sedation with xylazine accompanied by regulation of body temperature does not affect the EBA value nor its contralateral suppression. Nevertheless, anesthesia should be avoided, even with control of body temperature. The second goal of this study was to identify the specific cochlear contribution to the raw RW signal. Thus recordings were performed in normal and deafened animals and analyzed in the frequency band 0.5-2.5 kHz and also in the other frequency bands of 5-50 Hz, 50-150 Hz, and 150-500 Hz. The results indicate that most of the cochlear activity lies in the frequency band 0.5-2.5 kHz, with also some minor contribution coming from the 150- to 500-Hz band. Analysis and comparison of power values in the different conditions indicate that specific cochlear EBA power was about 60 microV2. From a commonly accepted mean background discharge rate of 50 spikes/s (sp/s), the EBA power without CLWN should have been around 4.4 microV2 if the fibers' activity was random. This difference suggests that there is probably some degree of synchrony between individual fibers. There was a reduction of approximately 45% during CLWN stimulation. This suppression might correspond to a reduction in both discharge rate and synchrony of the fibers.
Laboratoire d'Audiologie Experimentale et Clinique Universite de Bordeaux 2 Hopital Pellegrin France
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14044226
- 003
- CZ-PrNML
- 005
- 20140314105252.0
- 007
- ta
- 008
- 140130s1997 gw d f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)9348125
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Lima da Costa, D. $u Laboratoire d'Audiologie Experimentale et Clinique, Universite de Bordeaux II, Hopital Pellegrin, France.
- 245 10
- $a Bioelectrical cochlear noise and its contralateral suppression: relation to background activity of the eighth nerve and effects of sedation and anesthesia / $c da Costa D Lima, JP Erre, de Sauvage R Charlet, J Popelar, JM Aran
- 504 __
- $a Literatura
- 520 9_
- $a The bioelectrical activity of the cochlea, without any ipsilateral acoustic stimulation, was recorded in awake guinea pigs (GPs) between electrodes chronically implanted at the round window (RW) and the skull. Measuring its power in the band centered around 1.0 kHz (0.5-2.5 kHz) provided an indirect measure of the ensemble background (EBA) activity of the eighth nerve. Contralateral white-noise (CLWN) stimulation reduced this EBA, presumably by activation of medial olivocochlear fibers. The aim of the investigation was to validate measurements of EBA and of its contralateral suppression in order to study the medial efferent function. The first goal was to find the best conditions for recording the EBA in the absence of ipsilateral stimulation and for studying its suppression by contralateral acoustic stimulation, which implies that no noise was generated by the experimental animal. Thus recordings were compared in normal, awake GPs and in GPs under sedation with xylazine, anesthetized with a combination of xylazine and ketamine, and with and without temperature regulation. In order to monitor the effects of sedation and anesthesia, the recordings were analyzed not only in the 0.5- to 2.5-kHz frequency band but also in the other frequency bands, 5-50 Hz, 50-150 Hz, and 150-500 Hz, which presumably include general central and neuromuscular contributions. The results show that sedation with xylazine accompanied by regulation of body temperature does not affect the EBA value nor its contralateral suppression. Nevertheless, anesthesia should be avoided, even with control of body temperature. The second goal of this study was to identify the specific cochlear contribution to the raw RW signal. Thus recordings were performed in normal and deafened animals and analyzed in the frequency band 0.5-2.5 kHz and also in the other frequency bands of 5-50 Hz, 50-150 Hz, and 150-500 Hz. The results indicate that most of the cochlear activity lies in the frequency band 0.5-2.5 kHz, with also some minor contribution coming from the 150- to 500-Hz band. Analysis and comparison of power values in the different conditions indicate that specific cochlear EBA power was about 60 microV2. From a commonly accepted mean background discharge rate of 50 spikes/s (sp/s), the EBA power without CLWN should have been around 4.4 microV2 if the fibers' activity was random. This difference suggests that there is probably some degree of synchrony between individual fibers. There was a reduction of approximately 45% during CLWN stimulation. This suppression might correspond to a reduction in both discharge rate and synchrony of the fibers.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a akustická stimulace $7 D000161
- 650 02
- $a aminoglykosidy $7 D000617
- 650 02
- $a anestezie $7 D000758
- 650 02
- $a zvířata $7 D000818
- 650 02
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 02
- $a tělesná teplota $x fyziologie $7 D001831
- 650 02
- $a kochlea $x fyziologie $x účinky léků $7 D003051
- 650 02
- $a hluchota $x patofyziologie $7 D003638
- 650 02
- $a diuretika $x farmakologie $7 D004232
- 650 02
- $a kyselina ethakrynová $x farmakologie $7 D004976
- 650 12
- $a sluchové evokované potenciály $x účinky léků $7 D005072
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a funkční lateralita $x fyziologie $x účinky léků $7 D007839
- 650 02
- $a furosemid $x farmakologie $7 D005665
- 650 02
- $a morčata $7 D006168
- 650 12
- $a hypnotika a sedativa $x farmakologie $7 D006993
- 650 02
- $a nervus vestibulocochlearis $x fyziologie $x účinky léků $7 D000159
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Erre, J. P.
- 700 1_
- $a Charlet de Sauvage, R.
- 700 1_
- $a Popelář, Jiří, $d 1949- $7 xx0085571
- 700 1_
- $a Aran, J. M. $7 gn_A_00007969
- 773 0_
- $t Experimental Brain Research $x 0014-4819 $g Roč. 116, č. 2 (1997), s. 259-269 $p Exp Brain Res $w MED00009710
- 773 0_
- $p Exp Brain Res $g 116(2):259-69, 1997 Sep $x 0014-4819
- 910 __
- $a ABA008 $b A 3708 $y z $z 0
- 990 __
- $a 20140130103323 $b ABA008
- 991 __
- $a 20140314105301 $b ABA008
- 999 __
- $a ok $b bmc $g 1008931 $s 842756
- BAS __
- $a 3
- BMC __
- $a 1997 $b 116 $c 2 $d 259-269 $i 0014-4819 $m Experimental Brain Research $x MED00009710 $n Exp Brain Res
- GRA __
- $a IZ3108 $p MZ0
- LZP __
- $a 2014-01/ewbo